GP utilisation by education level among adults with COPD or asthma: A cross-sectional register-based study by Hetlevik, Øystein et al.
ARTICLE OPEN
GP utilisation by education level among adults with COPD
or asthma: a cross-sectional register-based study
Øystein Hetlevik1, Hasse Melbye2 and Sturla Gjesdal1
There is a marked socioeconomic gradient in the prevalence of chronic obstructive pulmonary disease (COPD) and asthma, but a large
proportion of patients remain undiagnosed. It is a challenge for general practitioners (GPs) to both identify patients and contribute to
equity and high quality in services delivered. The aim of this study was to identify patients with COPD and asthma diagnoses recorded
by GPs and explore their utilisation of GP services by education level. This was a cross-sectional, national, register-based study from
Norwegian general practice in the period 2009–2011. Based on claims from GPs, the number of patients aged ⩾ 40 years with a
diagnosis of COPD or asthma and their GP services utilisation were estimated and linked to the national education database.
Multivariate Poisson and logistic regression models were used to explore the variations in GP utilisation. In the population aged ⩾ 40
years, 2.8% had COPD and 3.8% had asthma according to GPs’ diagnoses. COPD was four times more prevalent in patients with basic
education than higher education; this increase was ⩽ 80% for asthma. Consultation rates were 12% higher (Po0.001) for COPD and
25% higher (Po0.001) for asthma in patients with low versus high education in the age group of 40–59 years after adjusting for
comorbidity, and patient and GP characteristics. Approximately 25% of COPD patients and 20% of asthma patients had ⩾ 1 spirometry
test in general practice in 2011, with no significant education differences in adjusted models. The higher consultation rate in
lower-education groups indicates that GPs contribute to fair distribution of healthcare.
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INTRODUCTION
Epidemiological studies across Europe indicate a prevalence of
chronic obstructive pulmonary disease (COPD) among adults
of up to 10%, as defined by reduced lung function.1,2 A recent
population study in Norway showed a prevalence of 7.1% for
moderate disease, as defined by Global Initiative for Chronic
Obstructive Lung Disease (GOLD) stage II, and 1.2% for severe
disease (GOLD stage III–IV).2 However, the prevalence of COPD
diagnoses according to medical records is lower, and it indicates
that two in three people with COPD may be undiagnosed.3,4 The
prevalence of asthma is estimated at 4–7% in people aged ⩾ 45
years.5 COPD and asthma are partly overlapping diseases,6,7 and
differentiating between them is sometimes difficult in general
practice.8–10
There appears to be a socioeconomic gradient in the
prevalence of COPD and asthma.11–17 A Norwegian population-
based study found a fourfold increase in obstructive lung disease
among people aged 440 years with primary education only
compared with those with college education or higher, after
adjusting for smoking habits and occupational exposures.13 Lower
socioeconomic status (SES) has also been found to be associated
with reduced health-care access, infrequent monitoring with
spirometry and worsening of the prognosis of COPD.11,18–20
In general, the rate of general practitioner (GP) consultations in
Norway is higher among patients in lower socioeconomic groups,
whereas this association is reversed in specialised care.21 To our
knowledge, there are no studies on variation in GP utilisation
related to SES among patients with asthma or COPD. Such
variations can be important in diseases with marked SES gradients.
In many countries, GPs have the main responsibility to diagnose
and follow-up patients with mild-to-moderate grades of COPD or
asthma,22,23 involving the specialist only in severe disease.
Increasing use and improving skills in the use of spirometry have
been shown to identify more patients with COPD than symptom
assessment alone and may lead to improved treatment.24,25
Current guidelines for COPD and asthma care include regular use
of spirometry in general practice.22,23,26 In a Norwegian study
from 2007, 91% of GP practices reported that they had a
spirometer, and that the test was performed by practice assistants
in 66% of cases.27
Patients with obstructive lung disease often also need health
services for comorbid conditions that have an important impact
on function and quality of life.28,29 From this perspective, an
assessment of GPs’ total care for patients with COPD and asthma
may reveal useful information for health-care development.
The aims of this study were first to estimate possible differences
in the prevalence of COPD and asthma diagnoses recorded by GPs
in adults by education level, and second to assess the variation in
utilisation of GP services in patients with such diseases according
to education level and other GP and patient characteristics,
including comorbidity.
RESULTS
In Norway, during 2009–2011, according to GP claims, 67,832
people (2.8%) received a COPD diagnosis and 109,771 (3.8%)
received an asthma diagnosis in the total population aged ⩾ 40
years. As 17,297 of these patients were given both a COPD and an
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asthma diagnosis by the GP during the 3-year period, the total
number of patients diagnosed with obstructive pulmonary disease
were 160,306 (6.7%). Figures 1 and 2 show the prevalence of
obstructive lung diseases recorded by Norwegian GPs by gender,
age and educational level.
Among patients with COPD, 44% had only basic education, 47%
had intermediate education and 7% had higher education, and for
2% the data were missing. The respective figures for patients with
asthma were 27, 49 and 20%, and 4% missing.
Comorbidity
GP diagnoses collected during 2009–2011 showed a high
frequency of comorbid conditions among patients with
obstructive lung diseases (Table 1), increasing with lower level
of education. The prevalence of depression and anxiety, recorded
by GPs, decreased with age, whereas the somatic conditions
increased with age.
Among COPD patients aged 40–59 years, 26.5% in the highest
and 35.1% in the lowest education group had a consultation
with a psychological main diagnosis in 2011, compared with 18.4
and 27.7% among patients with asthma (not tabulated). These
percentages were lower and showed less variation among
patients aged ⩾ 60 years.
GP service utilisation
Table 2 shows a gradual decrease in consultation rates with
increasing education level. More than 49% of patients among all
COPD patients had five consultations or more.
COPD was used as the main diagnosis by the GP in 22.0%
(N= 97,825) of all consultations among patients in the COPD
group, and asthma was the main diagnosis in 14.4% (N= 72,118)
of consultations among patients with asthma.
Approximately 25% of COPD patients and 20% of asthma
patients had at least one spirometry test in general practice
in 2011.
When comparing the quartiles of GP group practices according
to general use of spirometry, the annual rate per 100 list patients
was o1 in the lowest quartile, 1–2 in the second, 2–3.6 in the
third and 43.6 in the quartile with most frequent use of
spirometry.
Predictors for higher GP consultation rates
In unadjusted analyses (not shown in tables) using education level
as a predictor for consultation rates with high education as
reference, the COPD patients with basic education only had an
incident risk ratio of 1.21 (95% CI = 1.14–1.28) in the age group of
40–59 years and 1.06 (1.03–1.10) in the age group ⩾ 60 years. The
incident risk ratios among asthma patients was 1.40 (1.36–1.43)
and 1.18 (1.14–1.21), respectively, for these age groups. The effect
of education was reduced, but it was still significant in a
multivariate model except in COPD patients aged ⩾ 60 years
(Table 3). The presence of a comorbid condition was significantly
associated with increased consultation rates in patients with any
obstructive lung disease in both age groups (Table 3).
Predictors for the use of spirometry
There was a slight increase in spirometry rate with higher
education in unadjusted analyses. However, multivariate analyses
showed no association between education level and the use of
spirometry in any of the age or diagnosis groups in multivariate
models (Table 4). Stratified analyses revealed no gender
differences (not tabled).
However, the rate of spirometry tests in the practice population
in the group practice that the regular GP belonged to had a
significant impact, increasing the odds for spirometry six to nine




The present register study based on the data from all Norwegian
GPs showed a prevalence of COPD of 2.8% and 3.8% for asthma
recorded by GPs in the population aged ⩾ 40 years. For COPD, the
prevalence as recorded by GPs was four times higher in low
compared with high education groups. Among women aged
40–59 years, the prevalence of asthma diagnosis in GP medical
records increased from 4.1 to 7.4% when comparing higher with
low education groups, with markedly less variation in the other
age and gender groups.
The GP consultation rate was higher in lower education groups,
even after adjusting for comorbid conditions, whereas the use of
spirometry as an indicator of quality of care was not associated
with patients’ education level.
Interpretation of findings in relation to previously published work
Compared with a Norwegian population-based study showing
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Figure 1. Prevalence of COPD without asthma, both COPD and asthma, and asthma without COPD according to diagnoses used in Norwegian
general practice during 2009–2011 among patients aged 40–59 years by gender and education level.
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2.8% prevalence of COPD diagnoses recorded by GPs support
earlier findings of a large discrepancy between prevalence
estimates based on medical records and population-based
screening studies.3,4 The frequency of diagnosed COPD or asthma
found in GP medical records should not be used as prevalence
estimates at the population level, as a large proportion of these
patients either do not seek medical treatment or the disease is not
recognised by the physicians.
The prevalence of all GP-diagnosed obstructive lung diseases in
the age group 440 years is slightly higher than that found in a
Dutch study from general practice reporting 5.2%.30 However, the
prevalence of COPD diagnosis recorded by GPs of 2.8% in this
study is lower than the 5.3% found in a Canadian study also using
the data from electronic records.31
Among COPD patients in the present study, 25.5% also had an
asthma diagnosis registered, in line with a recent systematic
review showing that patients with both diagnoses constitute
between 15 and 55% of COPD patients, depending on the study
sample.7 However, the proportion of patients with COPD who also
had an asthma diagnosis registered was markedly lower than the
55% found in a previous Norwegian study from primary care,10
but they registered diagnoses over a 5-year time span.
The fourfold increase in the prevalence of COPD diagnoses
recorded by GPs from high to low education level is consistent
with other studies, but the smaller SES gradient seen among
asthma patients was in contrast to some previous studies.13,15
In the present study, health-care access indicated by GP
consultation rates corresponded with a low education profile,
whereas education was not associated with the use of spirometry.
This contrasts with a UK study showing lower use of spirometry
among socioeconomically deprived patients,18 and in part with a
Danish study that found lower use of spirometry among patients
with the highest level of education.19
Patient education and treatment plans are important elements
in care for patients with obstructive lung diseases, and low health
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Figure 2. Prevalence of COPD without asthma, both COPD and asthma, and asthma without COPD according to diagnoses used in Norwegian
general practice during 2009–2011 among patients aged ⩾ 60 years by gender and education level.
Table 1. Comorbid diagnoses used in GP records among adult patients diagnosed with COPD, both COPD and asthma, and asthma during
2009–2011 by their GP by diagnosis, education level and age group
COPD (no asthma) COPD and asthma Asthma (no COPD)
Educational level P-value Educational level P-value Educational level P-value
Basic Interm. High Basic Interm. High Basic Interm. High
Patients aged 40–59 years
N 3,697 4,567 875 1,925 2,196 483 11,464 24,065 12,881
Proportion with comorbid conditions (%)
Cardiovascular disease 11.0 9.3 6.5 o0.001 10.4 7.5 6.8 0.001 4.9 3.8 2.6 o0.001
Hypertension 19.7 21.2 18.5 0.099 20.1 19.9 17.6 0.47 19.1 18.7 14.3 o0.001
Diabetes 9.7 8.0 6.4 0.002 11.3 8.7 7.9 0.007 8.9 6.2 3.7 o0.001
Depression 22.5 19.1 18.4 o0.001 28.0 22.1 20.1 o0.001 20.3 15.0 13.3 o0.001
Anxiety 14.4 8.5 6.6 o0.001 18.7 10.5 6.8 o0.001 12.1 5.5 3.7 o0.001
Patients aged ⩾ 60 years
N 18,391 19,341 2,531 5,566 5,763 812 13,816 20,830 5,624
Proportion with comorbid conditions (%)
Cardiovascular disease 23.0 21.0 10.0 o0.001 22.6 19.4 17.6 o0.001 17.9 14.4 11.1 o0.001
Hypertension 35.6 34.6 31.9 0.001 37.6 38.1 35.5 0.35 45.1 40.9 35.0 o0.001
Diabetes 13.3 11.4 10.4 o0.001 13.9 12.2 10.8 0.005 15.7 11.5 8.0 o0.001
Depression 11.0 10.2 11.3 0.02 13.2 12.1 12.9 0.20 9.9 8.7 9.4 0.001
Anxiety 6.4 4.4 2.9 o0.001 8.6 6.2 4.3 o0.001 5.8 3.6 2.9 o0.001
Abbreviations: COPD, chronic obstructive pulmonary disease; GP, general practitioner; Interm., intermediate.
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Table 2. Utilisation of GP services in 2011 among adult patients diagnosed with COPD or asthma in Norwegian general practicea by diagnosis,















Patients aged 40–59 years
N 5,622 6,763 1,358 11,464 24,065 12,881
Gender (% male) 44.3 48.6 40.1 o0.001 35.6 41.2 35.0 o0.001
Age (mean) 52.5 53.1 52.2 o0.001 49.3 49.4 48.6 o0.001
Consultation rate (mean) 6.9 6.3 5.7 o0.001 6.0 5.0 4.3 o0.001
Proportion with of patients with:
⩾ 1 consultation (%) 95.0 95.2 94.7 0.76 93.4 92.4 91.3 o0.001
⩾ 5 consultation (%) 56.8 51.3 49.1 o0.001 49.2 42.7 34.6 o0.001
⩾ 10 consultation (%) 23.3 19.5 16.9 o0.001 18.3 13.2 9.6 o0.001
Proportion of patients with ⩾ 1
spirometry (%)
28.6 29.4 27.6 0.32 19.1 19.1 18.7 0.53
Patients aged ⩾ 60 years
N 23,961 25,104 3,343 13,816 20,830 5,624
Gender (% male) 44.2 53.7 57.6 o0.001 29.3 37.4 43.2 o0.001
Age (mean) 73.5 71.8 71.4 0.016 72.9 70.0 67.9 o0.001
Consultation rate (mean) 6.8 6.5 6.4 o0.001 6.3 5.8 5.3 o0.001
Proportion of patients with:
⩾ 1 consultation (%) 94.2 94.8 95.1 0.011 94.8 95.2 94.7 0.081
⩾ 5 consultation (%) 56.6 54.2 53.7 o0.001 53.6 49.8 44.7 o0.001
⩾ 10 consultation (%) 22.8 21.1 20.1 o0.001 19.8 16.8 14.6 o0.001
Proportion of patients with ⩾ 1
spirometry (%)
25.1 27.8 27.6 o0.001 18.2 20.5 20.8 o0.001
Abbreviations: COPD, chronic obstructive pulmonary disease; GP, general practitioner.
aPatient identified by diagnosis used by GPs in the 3-year period of 2009–2011.
bIncluding patients with COPD and both COPD and asthma.
cIncluding patients with asthma, but no COPD diagnosis.
Table 3. Associations between numbers of GP consultations in 2011 among patients diagnosed with COPD or asthma in Norwegian general
practice, and patient and GP characteristics
COPDa 40–59 years Asthma 40–59 years COPDa ⩾ 60 years Asthma ⩾ 60 years
IRR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
Education level
High (reference) 1 1 1 1
Intermediate 1.08** 1.02–1.14 1.13*** 1.11–1.15 1.00 0.97–1.04 1.04** 1.01–1.07
Low 1.12*** 1.06–1.18 1.25*** 1.22–1.28 1.02 0.99–1.05 1.04** 1.01–1.07
Male patient 0.83*** 0.81–0.86 0.77*** 0.76–0.79 0.96*** 0.95–0.98 0.91*** 0.90–0.93
Patient age (years) 0.99*** 0.99–0.99 1.00 1.00–1.00 1.01*** 1.00–1.01 1.01*** 1.01–1.01
Comorbid conditions
Cardiovascular diseases 1.30*** 1.23–1.38 1.37*** 1.31–1.42 1.24*** 1.22–1.27 1.29*** 1.26–1.32
Hypertension 1.12*** 1.08–1.16 1.26*** 1.23–1.29 1.06*** 1.04–1.08 1.12*** 1.10–1.14
Diabetes 1.37*** 1.30–1.45 1.48*** 1.43–1.52 1.28*** 1.25–1.31 1.34*** 1.30–1.37
Depression or anxiety 1.54*** 1.49–1.60 1.59*** 1.56–1.63 1.30*** 1.27–1.33 1.36*** 1.33–1.40
GP characteristics
GP male 1.09*** 1.04–1.14 1.06*** 1.03–1.08 1.04** 1.02–1.06 1.03* 1.00–1.06
GP age 0.996** 0.994–0.999 0.997*** 0.995–0.998 0.996*** 0.995–0.997 0.997*** 0.995–0.998
GP approved specialist
in FM
0.99 0.94–1.04 1.00 0.97–1.03 0.99 0.96–1.03 0.99 0.96–1.02
GP list size (per 100) 1.00 0.99–1.01 1.00 1.00–1.01 1.00 1.00–1.01 1.004* 1.00–1.01
N 13,286 47,012 50,651 39,096
Poisson regression models by diagnosis and age group.
Abbreviations: COPD, chronic obstructive pulmonary disease; CI, confidence interval; FM, familiy medicine; GP, general practitioner; IRR, incident risk ratio.
aPatients with both COPD and asthma diagnoses are included in the COPD group.
*Po0.05, **Po0.01, ***Po0.001.
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educational level,33 and higher consultation rates for patients in
lower educational groups may indicate that GPs to some extent
address the increased need for patient education in this group.
Depression and anxiety have negative consequences on the
somatic morbidity and quality of life in patients with COPD,34 and
earlier findings have shown substantial psychosocial burden
related to COPD.28 We found that one-third of COPD patients
had a GP consultation in 2011 with a psychological diagnosis and
19–24% of the patients aged 40–59 years with COPD received a
GP diagnosis of depression during the previous 3 years. This
indicates that Norwegian GPs address mental health problems to
a considerable extent in their consultations with patients with
asthma or COPD.
Strengths and limitations of this study
This was a nationwide study and included claims from all regular
GPs in Norway, thus avoiding the selection bias that is common in
studies recruiting GPs who wish to participate in research. We
used complete data on GP utilisation from 1 year (2011), including
all consultations with the GPs in the national list patient systems,
covering 99.5% of the population.
One major limitation is that 90% of claims reported to the
Norwegian Health Economics Administration (HELFO) include only
one International Classification of Primary Health Care code, even
if the GP deals with several issues in the consultation. This may
result in underestimations of the number of patients diagnosed
with COPD and asthma by the GPs. When patients come for other
conditions, the COPD or asthma diagnoses may not be reported
even if known by the GP. Correspondingly, there is probably an
underreporting of comorbid conditions as well. In 2011, 237,034
people aged ⩾ 40 years were dispensed bronchodilators in
Norway, according to the National Prescription Database35, and
probably most of these prescriptions were given by GPs. The
present study identified 160,306 people with the diagnosis of
obstructive lung disease in GP records, and this discrepancy
indicates that the diagnosis in claims data underestimates the
number of patients with a known diagnosis of asthma or COPD in
general practice. However, data from prescription databases are
not ‘gold standard’, because some people receive a prescription
for cough or dyspnoea without a diagnosis of COPD or asthma,
whereas patients with obstructive lung disease sometimes do not
use their medication.36
There is also uncertainty with the diagnostic precision and use
of defined criteria of COPD and asthma in general practice. In a
Norwegian study, 68% of GP-registered COPD diagnoses could be
verified by spirometry.10 A proportion of patients diagnosed with
COPD who did not fulfil the diagnostic criteria had asthma and
vice versa.8 The shift in the use of the diagnosis from asthma to
COPD shown in recent decades may still not be complete,37 and a
proportion of patients diagnosed with asthma may have
COPD. Therefore, a strength of this study is that both patients
with COPD and asthma diagnoses were included. However,
because of this uncertainty of accuracy of the diagnosis in general
practice, the estimated frequency of the asthma and COPD
overlap syndrome must be used with precaution.
During 2011, spirometry tests were performed in fewer than
one-quarter of patients with COPD and asthma, a rate far below
the recommendation for annual spirometry.22 The present study
has no data from secondary care, but some of the patients
identified by the GPs are followed up by a pulmonary specialist.
From other sources, we know that 0.3% of the population aged
445 years were hospitalised in 2011 with COPD as the main
diagnosis, and there were ~ 23,000 out-patient consultations with
COPD-related diagnoses in the same year.38 This represents
approximately one-quarter of the GP consultations with the COPD
diagnosis used as the main reason for contact.
Table 4. Patient and GP characteristics associated with ⩾ 1 spirometry test performed in Norwegian general practice in 2011 among patients
diagnosed with COPD or asthma during 2009–2011
COPDa 40–59 years Asthma 40–59 years COPDa ⩾ 60 years Asthma ⩾ 60 years
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Education level
High (reference) 1 1 1 1
Intermediate 1.07 0.94–1.23 1.03 0.97–1.09 1.00 0.91–1.09 1.04 0.96–1.12
Low 1.05 0.91–1.21 1.05 0.97–1–13 0.95 0.87–1.04 0.99 0.90–1.08
Male patient 1.09* 1.01–1.18 1.04 0.99–1.10 1.10*** 1.05–1.15 1.05 0.99–1.11
Patient age (years) 1.00 0.99–1.01 1.00 1.00–1.01 0.97*** 0.97–0.98 0.98*** 0.98–0.98
Spirometry rate in the practiceb
Lowest quartile 1 1 1 1
Medium–low 1.99*** 1.65–2.42 2.24*** 1.93–2.60 2.31*** 2.02–2.66 2.03*** 1.72–1.39
Medium–high 3.33*** 2.76–4.03 3.28*** 2.84–3.79 3.69*** 3.23–4.22 3.50*** 2.98–4.11
Highest quartile 6.51*** 5.38–7.88 7.43*** 6.39–8.63 7.96*** 6.91–9.16 8.79*** 7.46–10.37
GP characteristics
GP male 1.14* 1.02–1.27 1.08 0.99–1.19 1.11* 1.03–1.20 1.15** 1.04–1.27
GP age 1.00 0.99–1.00 1.00 0.99–1.00 1.00 0.99–1.00 0.995* 0.990–1.00
GP approved specialist
in FM
1.03 0.91–1.17 1.05 0.95–1.16 0.99 0.89–1.10 1.02 0.90–1.16
GP list size (per 100) 1.01 1.00–1.03 1.03*** 1.01–1.04 0.99** 1.01–1.03 1.04*** 1.02–1.06
N 13,325 47,166 50,818 39,182
Logistic regression models by diagnosis and age group.
Abbreviations: COPD, chronic obstructive pulmonary disease; FM, familiy medicine; GP, general practitioner; OR, odds ratio.
aPatients with both COPD and asthma diagnoses are included in the COPD group.
bThe rate of spirometry use in the total (group) practice the patient belongs to, divided in quartiles.
*Po0.05, **Po0.01, ***Po0.001.
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The utilisation of specialist out-patient care is higher among
patients in higher, compared with lower, educational groups, and
may contribute to the opposite educational difference seen in
general practice.21
Educational level, shown to predict outcome in patients with
COPD,20 and seldom changing among individuals above the age
of 40 years, was used as the marker of SES in this study. SES
markers such as income or occupation could have been used as
well, but a common limitation of these markers is the lack of
recent data for the oldest part of the population that constitutes a
large proportion of the present study population. However, using
data on income or occupation among patients below 65 years
could have given a broader view on SES variations in GP
utilisation.
Implications for future research, policy and practice
The prevalence of COPD diagnoses recorded by GPs in this study
was about one-quarter of estimates found in population-based
screening studies.2 Reasons for underdiagnoses are diverse, but
the lack of symptom presentation is one.39 GPs could be more
active in case-finding, and they have the potential to increase the
use of spirometry among adult patients with respiratory
symptoms and smoking history.40,41
There is, however, an ongoing discussion as to what level
of disease will be associated with improved health as a result
of a COPD diagnosis with or without subsequent preventive
interventions and medical treatment.40,41
Conclusion
The higher consultation rate for COPD in lower education groups
in this study adds to previous evidence that GP services may be a
tool for promoting a ‘fair’ distribution of healthcare. Improved care
for patients with COPD and asthma, and their comorbidities,
should be an important element in a future comprehensive GP
service.
MATERIALS AND METHODS
A register-based, cross-sectional, nationwide study from general practice in
Norway in 2009–2011 was conducted based on three national registers.
The KUHR database contains all claims for fee-for-service from regular
GPs. For each patient-related contact, the GP sends a claim to the
Norwegian Health Economics Administration (HELFO) along with the
patient’s personal identity number. The claims are based on the GP
tariff including codes for consultation and use of spirometry, and one or
more diagnoses according to the International Classification of Primary
Health Care.
The Regular GP database has information about all regular GPs
contracted to municipalities and to the HELFO, including age and gender
of the GPs, their patient list size, information about group practices and the
practice municipality. This database also includes the identity of the
patients on each list.
Information on education was retrieved from the National Educational
Database.
The information from these databases was linked by Statistics Norway
based on personal identity numbers and anonymously made available to
researchers, with the necessary permission from the Data Inspectorate.
Study population
All Norwegian residents aged 40 years or older in 2011 and all GPs were
included.
Classification of patient groups
On the basis of the diagnoses used in GP claims from 2009 to 2011, all
patients given the diagnosis of COPD (R95) or asthma (R96) were identified
and grouped into an asthma group, a COPD group and a third group of
patients with both diagnoses, the asthma and COPD overlap syndrome
classified as a phenotype of COPD.7 This group is presented as a separate
group in descriptive figures and tables. However, the patients with both
diagnoses were included in the COPD group in regression analyses,
because variation of educational level and results from preliminary
regression analyses were similar in these groups.
The term ‘prevalence of COPD (or asthma) diagnoses recorded by GPs’
refers to the proportion of registered patients where these diagnoses were
recorded in the GPs’ medical records and reported to the HELFO in a claim
during 2009–2011.
Outcome measure
To estimate the variations in care across strata of educational level,
consultation rates in 2011 were estimated as a continuous variable. Use of
spirometry test in 2011—one or more times versus no tests—was also
identified. These outcomes were used in the regression analyses.
Explanatory variables
The patient characteristics included were age, gender and education
grouped into three levels: basic education (o13 years), intermediate
education (13–15 years) and high education (⩾16 years).
Comorbid conditions were identified using International Classification of
Primary Health Care diagnoses in GP claims from the period 2009 to 2011,
and the following conditions were used as explanatory variables: diabetes
(T89–90), hypertension (K85–87), cardiovascular disease (K74–76 and
K89–91), depression (P76) and anxiety (P74).
The GP characteristics included were age, gender, being approved as
specialist in family medicine or not and list size for each GP.
Practice characteristics were list size of the entire group practice and the
total number of spirometry tests performed during 2011 based on all
claims from all GPs in each group practice. The practices were grouped
into quartiles based on the rate of spirometry in the total population listed
in the group practice.
Statistical analysis
One-way analysis of variance and χ2-test were used to compare the
education distribution, comorbidities and GP service utilisation among
patients with COPD or asthma.
Poisson regression models with robust estimates of s.d. were used to
analyse the association between total number of GP consultations, and
patients’ and GPs’ characteristics. Incident risk ratios are presented and can
be interpreted as the increase in rate of the outcome (consultation rate),
given that all other variables are unchanged. Logistic regression models
were used to identify predictors for the use of spirometry. In the regression
models, there is no independency because the patients are linked to a
regular GP. This was taken into account using the regular GP as clusters in
a two-level model in the analyses. A P-value o0.05 was considered
significant. Stata Statistical Software (Release 13; College Station, TX, USA)
was used.
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